Century Therapeutics, Inc.
Total Trades
40
Buys
3
Sells
31
Largest Trade
N/A
Insiders
7
Institutional Funds
29
Inst. Value
$1M+
Activist Filings
26
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Carr Douglas | SVP Finance & Oper… | SELL | <$1K | 323 | $1.82 | Feb 5, 2026 |
| Cowan Chad | Chief Scientific O… | BUY | $15K–$50K | 58K | $0.85 | Dec 29, 2025 |
| Pfeiffenberger Brent | President and CEO | BUY | $15K–$50K | 52K | $0.58 | Dec 16, 2025 |
| Carr Douglas | SVP Finance & Oper… | SELL | <$1K | 257 | $0.53 | Dec 10, 2025 |
| Russotti Gregory | See Remarks | SELL | <$1K | 526 | $0.53 | Dec 10, 2025 |
| Cowan Chad | Chief Scientific O… | SELL | $1K–$15K | 5K | $0.50 | Nov 24, 2025 |
| Pfeiffenberger Brent | President and CEO | BUY | $15K–$50K | 35K | $0.50 | Nov 20, 2025 |
| Pfeiffenberger Brent | President and CEO | SELL | $1K–$15K | 32K | $0.45 | Nov 19, 2025 |
| Carr Douglas | SVP Finance & Oper… | SELL | <$1K | 292 | $0.59 | Nov 5, 2025 |
| Carr Douglas | SVP Finance & Oper… | SELL | <$1K | 263 | $0.50 | Sep 10, 2025 |
| Pfeiffenberger Brent | President and CEO | SELL | <$1K | 488 | $0.50 | Sep 10, 2025 |
| Russotti Gregory | See Remarks | SELL | <$1K | 539 | $0.50 | Sep 10, 2025 |
| Carr Douglas | SVP Finance & Oper… | SELL | $1K–$15K | 5K | $0.62 | Jun 11, 2025 |
| Farid Adrienne | Chief Operations O… | SELL | <$1K | 552 | $0.62 | Jun 11, 2025 |
| Pfeiffenberger Brent | President and CEO | SELL | <$1K | 475 | $0.62 | Jun 11, 2025 |
| Russotti Gregory | See Remarks | SELL | <$1K | 526 | $0.62 | Jun 11, 2025 |
| Pfeiffenberger Brent | President and CEO | SELL | $15K–$50K | 30K | $0.55 | May 20, 2025 |
| Farid Adrienne | Chief Operations O… | SELL | <$1K | 1K | $0.55 | May 7, 2025 |
| Carr Douglas | SVP Finance & Oper… | SELL | <$1K | 295 | $0.55 | May 7, 2025 |
| Pfeiffenberger Brent | President and CEO | GRANT | N/A | 522K | — | Mar 12, 2025 |
| Pfeiffenberger Brent | President and CEO | SELL | $1K–$15K | 2K | $0.61 | Mar 12, 2025 |
| Russotti Gregory | See Remarks | GRANT | N/A | 120K | — | Mar 12, 2025 |
| Russotti Gregory | See Remarks | SELL | $1K–$15K | 2K | $0.61 | Mar 12, 2025 |
| Farid Adrienne | Chief Operations O… | GRANT | N/A | 120K | — | Mar 12, 2025 |
| Farid Adrienne | Chief Operations O… | SELL | $1K–$15K | 2K | $0.61 | Mar 12, 2025 |
| Carr Douglas | SVP Finance & Oper… | GRANT | N/A | 96K | — | Mar 12, 2025 |
| Carr Douglas | SVP Finance & Oper… | SELL | <$1K | 1K | $0.61 | Mar 12, 2025 |
| Farid Adrienne | Chief Operations O… | SELL | $1K–$15K | 1K | $1.23 | Nov 5, 2024 |
| Carr Douglas | SVP Finance & Oper… | SELL | <$1K | 283 | $1.23 | Nov 5, 2024 |
| Russotti Gregory | See Remarks | SELL | $1K–$15K | 586 | $2.50 | Jul 31, 2024 |
| Russotti Gregory | See Remarks | SELL | $1K–$15K | 5K | $2.84 | Jun 24, 2024 |
| Russotti Gregory | See Remarks | SELL | $1K–$15K | 5K | $3.00 | Jun 6, 2024 |
| Russotti Gregory | See Remarks | SELL | $15K–$50K | 5K | $3.10 | Apr 24, 2024 |
| Farid Adrienne | Chief Operations O… | SELL | $1K–$15K | 485 | $4.86 | Feb 21, 2024 |
| Farid Adrienne | Chief Operations O… | EXERCISE | <$1K | 485 | $1.03 | Feb 21, 2024 |
| Carr Douglas | SVP Finance & Oper… | SELL | $1K–$15K | 1K | $4.14 | Feb 7, 2024 |
| Farid Adrienne | Chief Operations O… | SELL | $15K–$50K | 4K | $4.14 | Feb 7, 2024 |
| Borges Luis | Chief Scientific O… | EXERCISE | $100K–$500K | 350K | $1.03 | Mar 23, 2023 |
| Borges Luis | Chief Scientific O… | SELL | $500K+ | 145K | $3.73 | Mar 23, 2023 |
| Versant Venture Capital VI, L.P. | 10% Owner | SELL | $1M+ | 550K | $13.03 | Aug 11, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 29 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Point72 Asset Management, L.P. | 6.0M | $1M+ | SH |
| Spruce Street Capital LP | 1.4M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.3M | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 1.2M | $1M+ | SH |
| Syncona Portfolio Ltd | 1.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 379K | $100K–$500K | SH |
| GSA CAPITAL PARTNERS LLP | 333K | $100K–$500K | SH |
| VANGUARD GROUP INC | 268K | $100K–$500K | SH |
| UBS Group AG | 215K | $100K–$500K | SH |
| STATE STREET CORP | 127K | $100K–$500K | SH |
| RAYMOND JAMES FINANCIAL INC | 91K | $50K–$100K | SH |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 78K | $50K–$100K | SH |
| PRUDENTIAL FINANCIAL INC | 60K | $50K–$100K | SH |
| JANE STREET GROUP, LLC | 45K | $15K–$50K | SH |
| Parametrica Management Ltd | 28K | $15K–$50K | SH |
| Quadrant Private Wealth Management, LLC | 15K | $15K–$50K | SH |
| Advisors Asset Management, Inc. | 8K | $1K–$15K | SH |
| SIMPLEX TRADING, LLC | 2K | $1K–$15K | SH |
| BlackRock, Inc. | 2K | $1K–$15K | SH |
| JPMORGAN CHASE & CO | 2K | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Point72 Asset Management, L.P.
SC 13G/A · Feb 17, 2026
6.8%
6.0M shares
SC 13G · Jan 16, 2026
9.9%
17.9M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G · Jan 16, 2026
7.1%
13.0M shares
SC 13G · Jan 16, 2026
7.1%
13.0M shares
SC 13G · Jan 15, 2026
4.9%
8.9M shares
SC 13G · Jan 15, 2026
7.3%
13.5M shares
Point72 Asset Management, L.P.
SC 13G · Jan 5, 2026
5.4%
4.7M shares
Bain Capital Life Sciences Opportunities III, LP
SC 13G/A · Nov 14, 2025
4.1%
3.5M shares
SC 13G/A · May 15, 2025
3.7%
3.2M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Feb 14, 2025
4.7%
4.0M shares
SC 13G · Nov 27, 2024
5.4%
4.6M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Nov 14, 2024
6.4%
5.4M shares
SC 13G/A · Nov 14, 2024
3.8%
3.2M shares
SC 13G/A · Nov 12, 2024
3.0%
2.5M shares
SC 13G/A · Oct 26, 2024
0.0%
0 shares
Bain Capital Life Sciences Opportunities III, LP 2
SC 13G · Apr 25, 2024
6.6%
5.3M shares
SC 13G · Apr 22, 2024
5.8%
4.9M shares
SC 13G · Apr 18, 2024
6.1%
5.2M shares
SC 13D/A · Apr 9, 2024
5.0%
3.2M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G · Mar 4, 2024
5.4%
3.4M shares
SC 13G/A · Nov 13, 2023
6.4%
3.8M shares
Versant Venture Capital VI, L.P.
SC 13G/A · Feb 9, 2023
19.4%
11.5M shares
SC 13D/A · Oct 11, 2022
5.5%
3.2M shares
SC 13G · Feb 11, 2022
23.2%
12.7M shares
FUJIFILM Cellular Dynamics, Inc.
SC 13G · Feb 11, 2022
12.7%
7.0M shares
Versant Venture Capital VI, L.P.
SC 13G · Feb 11, 2022
22.6%
12.4M shares